146 related articles for article (PubMed ID: 35700595)
1. A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis.
Chen YQ; Xu XF; Xu JW; Di TY; Wang XL; Huo LQ; Wang L; Gu J; Zhou GH
Transl Oncol; 2022 Aug; 22():101467. PubMed ID: 35700595
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract][Full Text] [Related]
3. A novel web-based prognostic nomogram and the features influencing the curative effect of chemotherapy and radiotherapy for Paget's disease with invasive ductal carcinoma.
Qu J; Li C; Liu M; Wang Y; Sun S; Feng Z; Wu F; Zhang S; Zhao X
Am J Cancer Res; 2023; 13(10):4508-4530. PubMed ID: 37970339
[TBL] [Abstract][Full Text] [Related]
4. Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population-based study from China.
Wang DY; Li SF; Gao SL; Yuan P; Zhang BL
Cancer Med; 2023 Apr; 12(8):9644-9649. PubMed ID: 36952359
[TBL] [Abstract][Full Text] [Related]
5. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
6. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis.
Xu L; Wen N; Qiu J; He T; Tan Q; Yang J; Du Z; Lv Q
Front Oncol; 2020; 10():1718. PubMed ID: 33042815
[No Abstract] [Full Text] [Related]
7. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Breast Invasive Ductal Carcinoma Patients After Surgery: A Large Population-Based Study.
Feng Y; Zhang Y; Xiang Y; Guo K; Jin H; Ruan S; Guan Z
Front Surg; 2022; 9():779220. PubMed ID: 35402478
[TBL] [Abstract][Full Text] [Related]
9. Nomograms for predicting survival in patients with gastric carcinoid or neuroendocrine carcinoma based on the SEER database.
Shi H; Sun SY; Liu SS; Liu XN; He YS; Peng Q
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3071-3081. PubMed ID: 37070910
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction.
Wang C; Xu Y; Lin Y; Zhou Y; Mao F; Zhang X; Shen S; Zhang Y; Sun Q
Breast; 2022 Jun; 63():61-70. PubMed ID: 35334240
[TBL] [Abstract][Full Text] [Related]
11. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
12. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
Huang Z; Zhou X; Tong Y; Zhu L; Zhao R; Huang X
BMC Cancer; 2021 Mar; 21(1):222. PubMed ID: 33663462
[TBL] [Abstract][Full Text] [Related]
13. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
14. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
16. Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study.
Dai D; Jin H; Wang X
Am J Cancer Res; 2018; 8(8):1576-1585. PubMed ID: 30210925
[TBL] [Abstract][Full Text] [Related]
17. Nomogram Predicts the Role of Primary Tumor Surgery on
Cui H; Dai L; Bao Y; Hu L; Zhou Z; Wang M; Lin S; Wu H; Ma X; Kang H
Front Oncol; 2022; 12():819531. PubMed ID: 35600374
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
Jiang AG; Cai X
BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic nomogram for early HER2-positive and lymph node-negative breast cancer.
Shi Q; Wang J; Ai X; Xuhong J; Ma D; Zhang Y; Qi X; Jiang J
Gland Surg; 2021 Jul; 10(7):2255-2265. PubMed ID: 34422596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
